TS (Tourette’s syndrome) affects over 100,000 people in the United States, according to statistics. The cause of this complex neuropsychiatric condition marked by involuntary vocal tics is unclear. While the severity of this problem varies greatly from patient to patient, research has shown that the condition generally improves with age. There is currently no treatment for Tourette’s syndrome. Legal cannabis, on the other hand, has been shown to help patients deal with the symptoms.Learn more at Grass Station 49 Recreational Marijuana Dispensary Chena Hot Springs Road – dispensary near fairbanks
The results were presented in the March 1999 issue of the American Journal of Psychiatry by researchers from the Medical School of Hanover in Germany’s Department of Clinical Psychiatry and Psychotherapy. According to their findings, a 25-year-old male patient with Tourette’s syndrome was successfully treated with a single 10 mg dose of MMJ in an unregulated accessible clinical trial. Within two hours of beginning cannabinoid therapy, the magnitude of the vocal tic fell from forty one to seven.
According to a study of the trial, there is sufficient evidence to suggest that cannabinoids are involved in the treatment of Tourette’s syndrome. The patient’s condition changed significantly during the procedure, and the effect lasted for about seven hours in a single session. For the first time, scientific data from several clinical trials supports the subjective perceptions of patients who smoked marijuana using a credible and valid rating scale. A single trial dose of medical marijuana was given to a dozen adult patients with Tourette’s syndrome in a double-blind, randomised, placebo-controlled study.
The preliminary findings presented by the researchers indicated that delta 9 THC treatment resulted in a significant increase in OCB (obsessive compulsive behaviour) and repetitive vocal tics as compared to placebo. Furthermore, investigators concluded that medical marijuana was not only safe and successful in treating these TS symptoms, but that the test subjects did not experience any cognitive decline after receiving it.
In a second randomised, placebo-controlled, randomised trial involving twenty-four patients, the same findings were observed. Over the course of six weeks, these patients were given daily doses of ten mg of medicinal cannabis. There were no negative effects on the test subjects’ verbal memory, recall, or learning. In reality, they saw a significant reduction in the tics that are associated with Tourette’s syndrome. The review of these results was published in the journal The Expert Opinions of Pharmacotherapy in October 2003.